NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球分子診斷市場(2021-2027)

Molecular Diagnostics Market 2021-2027

出版商 Orion Market Research Pvt Ltd 商品編碼 1025324
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球分子診斷市場(2021-2027) Molecular Diagnostics Market 2021-2027
出版日期: 2021年06月22日內容資訊: 英文
簡介

在預測期內,全球分子診斷市場預計將以 9.9% 的顯著複合年增長率增長。該市場增長的一個主要驅動力是全球艾滋病和 COVID-19 等傳染病的日益流行。癌症也是威脅生命的疾病之一,並支持市場的增長。然而,分子診斷設備的高成本阻礙了全球分子診斷市場的增長。

COVID-19 的傳播為全球分子診斷市場帶來了有利的增長。然而,其他應用的市場正在萎縮,因為它不用於治療其他主要疾病,包括癌症和艾滋病。

全球分子診斷市場按技術、產品和應用進行分類。根據技術,市場分為PCR、ISH、DNA微陣列、NSG、等溫核酸擴增等技術。按產品分為檢測設備、診斷試劑/試劑盒、服務軟件。按應用分為傳染病、癌症、心血管疾病、基因檢測、神經系統疾病等。在全球分子診斷市場,由於在蛋白質組學和基因組學領域的應用不斷擴大,PCR領域佔據了很大份額。例如,用於檢測 COVID-19 的 RT-PCR 測試由於 qRT-PCR 測試的增加而給市場帶來了顯著增長,這是該領域的一項先進技術。

本報告調查了全球分子診斷市場,概述了市場,分析了市場增長和障礙、市場機會、市場規模趨勢以及按技術、產品、應用和地區以及競爭條件進行的預測。, 提供系統信息,例如主要公司的簡介。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢

第三章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
    • 近期發展
  • 重要的戰略分析
  • COVID-19 對主要參與者的影響

第 4 章市場決定因素

  • 動機
  • 抑製器
  • 市場機會

第五章市場細分

  • 按技術
    • 聚合□鏈反應 (PCR)
    • 原位雜交 (ISH)
    • DNA微陣列
    • 下一代測序 (NGS)
    • 等溫核酸擴增
    • 其他
  • 按產品
    • 檢測設備
    • 診斷試劑和試劑盒
    • 服務和軟件
  • 按應用程序
    • 傳染病(包括 COVID-19)
    • 癌症
    • 心血管疾病 (CVD)
    • 基因檢測
    • 神經系統疾病
    • 其他

第六章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 其他領域

第 7 章公司簡介

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • AltheaDX, Inc.
  • AutoGenomics, Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Co.
  • Biocartis N.V.
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • CareDX, Inc.
  • Danaher Corp.
  • ELITech Group
  • Exact Science Corp.
  • F. Hoffmann-La Roche, Ltd.
  • Genetic Technologies, Ltd.
  • GenMark Diagnostics, Inc.
  • Grifols, S.A.
  • Hologic, Inc.
  • HTG Molecular Diagnostics, Inc.
  • MDxHealth Group
  • Merck KGaA
  • Oxford Nanopore Technologies Ltd.
  • QIAGEN GmbH
  • Sequenom, Inc.
  • Siemens Healthcare Pvt. Ltd.
  • Source BioScience, Ltd.
  • Thermo Fisher Scientific, Inc.
  • Veracyte, Inc.
目錄
Product Code: OMR2023736

Global Molecular Diagnostics Market Size, Share & Trends Analysis Report by Technology(Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), DNA Microarray, Next-Generation Sequencing (NGS), Isothermal Nucleic Acid Amplification, and Other Technologies), By Product(Testing Equipment, Diagnostic Reagents & Kits, and Services & Software), By Applications (Infectious Diseases, Cancer, Cardiovascular Disease (CVD), Genetic Testing, Neurological Disease, and Other) Forecast Period (2021-2027)

The global molecular diagnostics market is anticipated to grow at a substantial CAGR of 9.9% during the forecast period. The major factor fueling the growth of the market includes the rise in the prevalence of infectious diseases like AIDS and COVID-19 across the globe. Cancer is another life-threatening disease that is giving support to market growth. However, the expensive instruments of molecular diagnostics are restraining the growth of the global molecular diagnostics market.

The spread of COVID-19 had given lucrative growth to the global molecular diagnostics market. However, the market of other applications had reduced due to the sideline of the treatment of other major diseases including cancer and AIDS.

The global molecular diagnostics market is segmented based on technology, product, and applications. Based on the technology, the market is segmented into PCR, ISH, DNA microarray, NSG, isothermal nucleic acid amplification, and other technologies. Based on the product, the market is segmented into testing equipment, diagnostic reagents & kits, and services & software. Apart from this, by applications, the market is segmented into infectious diseases, cancer, CVD, genetic testing, neurological disease, and others. The PCR segment occupies the major share in the global molecular diagnostics market attributing to its increasing use in proteomics and genomics. For instance, the increased RT-PCR test to detect COVID-19 had given significant growth to the market; the qRT-PCR test is the advanced technology in this field.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America holds the major share in the global bioreactors market. However, emerging countries like India and China of Asia Pacific will show the fastest growth in the market.

The companies engaged in molecular diagnostics provide reagent kits and testing equipment for molecular diagnostic tests. The market players also provide molecular diagnostic services for the treatment and diagnosis of infectious diseases and cancer. The key players in the molecular diagnostics market include Becton Dickinson and Co., Abbott Laboratories, Inc., bioMerieux S.A., Bio-Rad Laboratories, Inc., Danaher Corporation, Nanopore Technologies, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches with innovation in current models, to stay competitive in the market. For instance, Hologic, Inc. had acquired Biotheranostics Inc. (US) in January 2021 to expand its product portfolio. Roche Diagnostics had acquired Stratos Genomics (US) in May 2020 to support the development of its nanopore technology and take access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX). Abbott Laboratories had launched a new product the ID NOW PoC testing system in March 2020.

Research Methodology

The market study of the global industrial fastenersmarket is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, researchpapers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Industrial FastenersMarket Research and Analysis by Product Type

Global Industrial FastenersMarket Research and Analysis by Material

Global Industrial FastenersMarket Research and Analysis by End-user

The Report Covers

Comprehensive research methodology of the globalindustrial fastenersmarket.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global industrial fastenersmarket.

Insights about market determinants that are stimulating the global industrial fastenersmarket.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Molecular Diagnostics Market
  • Recovery Scenario of Global Molecular Diagnostics Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Molecular Diagnostics Market by Technology
    • 5.1.1. Polymerase Chain Reaction (PCR)
    • 5.1.2. In Situ Hybridization (ISH)
    • 5.1.3. DNA Microarray
    • 5.1.4. Next-Generation Sequencing (NGS)
    • 5.1.5. Isothermal Nucleic Acid Amplification
    • 5.1.6. Other Technologies
  • 5.2. Global Molecular Diagnostics Market by Product
    • 5.2.1. Testing Instruments
    • 5.2.2. Diagnostic Reagents and Kits
    • 5.2.3. Services & Software
  • 5.3. Global Molecular Diagnostics Market by Applications
    • 5.3.1. Infectious Diseases (including COVID-19)
    • 5.3.2. Cancer
    • 5.3.3. Cardiovascular Disease (CVD)
    • 5.3.4. Genetic Testing
    • 5.3.5. Neurological Disease
    • 5.3.6. Other

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. Agilent Technologies, Inc.
  • 7.3. AltheaDX, Inc.
  • 7.4. AutoGenomics, Inc.
  • 7.5. Beckman Coulter, Inc.
  • 7.6. Becton Dickinson and Co.
  • 7.7. Biocartis N.V.
  • 7.8. bioMerieux S.A.
  • 7.9. Bio-Rad Laboratories, Inc.
  • 7.10. CareDX, Inc.
  • 7.11. Danaher Corp.
  • 7.12. ELITech Group
  • 7.13. Exact Science Corp.
  • 7.14. F. Hoffmann-La Roche, Ltd.
  • 7.15. Genetic Technologies, Ltd.
  • 7.16. GenMark Diagnostics, Inc.
  • 7.17. Grifols, S.A.
  • 7.18. Hologic, Inc.
  • 7.19. HTG Molecular Diagnostics, Inc.
  • 7.20. MDxHealth Group
  • 7.21. Merck KGaA
  • 7.22. Oxford Nanopore Technologies Ltd.
  • 7.23. QIAGEN GmbH
  • 7.24. Sequenom, Inc.
  • 7.25. Siemens Healthcare Pvt. Ltd.
  • 7.26. Source BioScience, Ltd.
  • 7.27. Thermo Fisher Scientific, Inc.
  • 7.28. Veracyte, Inc.

LIST OF TABLES

  • 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 2. GLOBAL PCRMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL ISHMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL DNA MICROARRAYMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL NSGMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATIONMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL OTHER TECHNOLOGIESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 9. GLOBAL TESTING EQUIPMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL DIAGNOSTIC REAGENTS AND KITS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL SERVICES & SOFTWARE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 13. GLOBAL MOLECULAR DIAGNOSTICS FOR INFECTIOUS DISEASESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL MOLECULAR DIAGNOSTICS FOR CANCERMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL MOLECULAR DIAGNOSTIC FOR CVDMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL MOLECULAR DIAGNOSTICS FORGENETIC TESTINGMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBALMOLECULAR DIAGNOSTICS FORNEUROLOGICAL DISEASESMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBALMOLECULAR DIAGNOSTICS for OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 20. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN MOLECULAR DIAGNOSTICSMARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 22. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 24. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 25. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 26. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 27. EUROPEAN MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 28. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 29. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 30. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)
  • 32. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 33. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2020-2027 ($ MILLION)
  • 34. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2020-2027 ($ MILLION)
  • 35. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATIONS, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET, 2021-2027 (%)
  • 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2020 VS 2027 (%)
  • 5. GLOBAL PCRMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 6. GLOBAL ISHMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 7. GLOBAL DNA MICROARRAY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL NSG MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL ISOTHERMAL NUCLEIC ACID AMPLIFICATIONMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 10. GLOBAL OTHER TECHNOLOGIES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY PRODUCT, 2020 VS 2027 (%)
  • 12. GLOBAL TESTING EQUIPMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 13. GLOBAL DIAGNOSTIC REAGENTS AND KITS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 14. GLOBAL SERVICES & SOFTWARE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY APPLICATIONS, 2020 VS 2027 (%)
  • 16. GLOBALMOLECULAR DIAGNOSTICS FORINFECTIOUS DISEASESMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 17. GLOBALMOLECULAR DIAGNOSTICS FOR CANCERMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 18. GLOBALMOLECULAR DIAGNOSTICS FOR CVDMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 19. GLOBALMOLECULAR DIAGNOSTICS FOR GENETIC TESTINGMARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 20. GLOBALMOLECULAR DIAGNOSTICS FOR NEUROLOGICAL DISEASES MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 21. GLOBALMOLECULAR DIAGNOSTICS FOR OTHER MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 22. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 23. NORTH AMERICAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 24. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 25. CANADA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 26. EUROPEAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 27. UK MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 28. GERMANY MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 29. SPAIN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 30. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 31. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 32. ROE MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 33. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 34. INDIA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 35. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 36. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 37. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 38. REST OF ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)
  • 39. REST OF THE WORLD MOLECULAR DIAGNOSTICS MARKET SIZE, 2017-2023 ($ MILLION)